Merger of Mylan and Pfizer's Upjohn wins EU nod with product sell-off agreement
admin 23rd April 2020 Uncategorised 0The proposed merger between Mylan and Pfizer’s Upjohn unit, though facing a delay due to the COVID-19 pandemic, has won EU antitrust clearance—but not without conditions. Upjohn’s top-selling drugs Lyrica, Xalatan and Xalacom, among others, came under scrutiny in certain
read more